Selvita is a pre-clinical CRO and drug discovery company founded in 2007 in Krakow, Poland. We offer support for drug discovery development at every stage of the early discovery phase up to the preclinical research.
The company was established in 2007 and currently employs over 520 scientists, among which 30% are PhDs.
Selvita's laboratories are located in Krakow, Poland and possess both GLP and GMP certification. Drug discovery clients of Selvita include more than fifty large and medium-sized pharmaceutical and biotechnology companies from USA and Europe.
Selvita offers integrated drug discovery projects helping biotech and pharma partners discover and develop new drugs. Our scientists have an extensive experience in several areas of life sciences, and we offer the following types of projects:
Selvita specializes in a broad spectrum of pharmacodynnamic in vitro studies used to analyze biosimilar product's activity in comparison to adequate reference compounds. We offer assays that are able to detect even minor changes in biological response to pharmacologically active substances.
Company offices are located in Cambridge, MA, San Francisco Bay Area in the USA as well as Krakow, Poland and Cambridge, UK.
Selvita also develops its own innovative drugs, which originate from research at Polish universities and later commercializes them with partners from the pharmaceutical industry. Currently company has focused its research and development efforts in the area of oncology.
"We requested a protein expression / refold from E. coli. Selvita remained in constant communication, was highly collaborative throughout the process and provided timely updates on the progress. Upon completion, Selvita kept in contact during the shipping/import process to ensure the product arrived safely at our location and is interested in receiving updates to make sure the protein meets our needs."
"A excellent lob. Very responsive to question and help through out the entire process Very professionally, timely done. Excellent quality"
Selvita has not received any endorsements.